Trapping malaria parasites inside host cell basis for new drugs
A P. falciparum parasite exits a host erythrocyte loaded with the calcium concentration indicator. High fluorescence of the calcium indicator indicates increased calcium concentration within the host cell. The image is pseudocolored, tending from black (the lowest calcium concentration), through green and yellow to red (the highest calcium concentration) to indicate relative calcium concentration within the host cell. Increased calcium induces calpain activation at the time of parasite egress, as a consequence of upstream host cell signaling. The nuclei of daughter parasites are stained blue in a diagonal pattern from the upper right to the lower left as the parasites are actively exiting the cell. The host cell is no longer uniformly circular since it has been lysed. This shows a high concentration of calcium within the host cell at the end of the parasite cycle, when the host cell lyses and necessary for host calpain activation and break down of the host cytoskeleton. Credit: Doron Greenbaum, Ph.D.
One of the most insidious ways that parasitic diseases such as malaria and toxoplasmosis wreak their havoc is by hijacking their host's natural cellular processes, turning self against self. Researchers from the Perelman School of Medicine, University of Pennsylvania and Johns Hopkins University, led by Doron Greenbaum, Ph.D., assistant professor of Pharmacology at Penn, have identified the cell signaling pathway used by these parasites to escape from and destroy their host cells and infect new cells—pointing the way toward possible new strategies to stop these diseases in their tracks. The study appears in Cell, Host and Microbe.
When the Plasmodium falciparum and Toxoplasma gondii parasites invade a host cell, they take up residence inside a "parasitophorous vacuole" (PV), growing and replicating themselves for about 48 hours. Then they burst out of the PV, completely destroying and dissolving the protein-based cytoskeleton of their host, freeing themselves to seek out and infect new host cells. Greenbaum's previous work showed that both P. falciparum and T. gondii hijack the calcium-regulated enzyme calpain from host cells and use it to break down host cytoskeleton. The current Cell, Host and Microbe study took the next step of identifying which host signaling pathway was involved, with the aim of derailing the parasite's escape route, trapping it inside the host cell and preventing it from spreading infection.
"We found an entire signaling pathway in the human host cell that the parasite engages, starting from a G-protein-coupled receptor, that the parasite uses to dismantle the cytoskeleton of the host cell, causing it to collapse," Greenbaum explains. "There's a complex series of proteins in this signaling cascade. One of the key proteins is protein kinase C [PKC]. We found a tremendous amount of biological validation for the existence and use of this pathway in both parasitic organisms."
Independent of calpain, the researchers also found that host PKC played an important role in the loss of protein adducin from the host cytoskeleton, contributing greatly to its collapse.
To test the role of the PKC signaling cascade in the disease process, Greenbaum and his collaborators tested known PKC inhibitors in both cell assays and in mouse models. These studies showed a marked decrease in parasitic infection for both P. falciparum and T. gondii. Greenbaum notes, "It's a human enzyme [PKC] that we're targeting, and by inhibiting it we've basically blocked the parasites from getting out. They're trapped and die within the host cells." A key advantage of such an approach, explains Greenbaum, is that "targeting a host protein will engender less resistance because the parasite has no genetic control over the host."
One of the inhibitors tested was a new orally available agent called sotrastaurin, a PKC inhibitor. This drug has already passed Phase I trials and is currently undergoing Phase II trials for various indications. In the mouse studies, sotrastaurin administration also resulted in a significant decrease in parasitemia and markedly increased survival rates against Plasmodium berghei ANKA, thus showing great potential as an oral antimalarial.
"We've piggybacked this line of research onto a drug class that's already vetted," says Greenbaum. "We're quite excited about that. We've found a compound that's already been used in trials in humans and is deemed safe."
Greenbaum and his team are hopeful that after more extensive animal testing, the next step could be human trials of sotrastaurin against malaria. This compound, or similar PKC inhibitors, could provide a multipronged weapon against malaria and other parasitic disease.
"This approach could be used as both a prophylactic and a treatment," Greenbaum says. "We have some indication that it could also used to block transmission."
Provided by University of Pennsylvania School of Medicine
- Locking Parasites in Host Cell Could Be New Way to Fight Malaria, Penn Study Shows Apr 04, 2009 | not rated yet | 0
- Team mimicking a natural defense against malaria to develop new treatments Dec 27, 2012 | not rated yet | 0
- Enzymes possible targets for new anti-malaria drugs Sep 21, 2011 | not rated yet | 0
- Scientists developing new class of malaria drugs using essential calcium enzyme Dec 27, 2012 | not rated yet | 0
- How Toxoplasma gondii gets noticed Jan 19, 2009 | not rated yet | 0
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...
Medical research 10 hours ago | 5 / 5 (1) | 0 |
Discovery of circadian clock in mice hair reveals period of time when damage from radiotherapy can be quickly repaired
Discovering that mouse hair has a circadian clock - a 24-hour cycle of growth followed by restorative repair - researchers suspect that hair loss in humans from toxic cancer radiotherapy and chemotherapy ...
Medical research 11 hours ago | 5 / 5 (2) | 1 |
Medical research 12 hours ago | 4.8 / 5 (6) | 2 |
New research from the University of Southampton has shown that blind and visually impaired people have the potential to use echolocation, similar to that used by bats and dolphins, to determine the location of an object.
Medical research 14 hours ago | not rated yet | 1 |
A novel vaccine study from South Dakota State University (SDSU) will headline the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference ...
Medical research 15 hours ago | not rated yet | 0
3 hours ago | not rated yet | 0 |
8 hours ago | 4.6 / 5 (12) | 3 |
11 hours ago | 4.8 / 5 (11) | 2 |
12 hours ago | 5 / 5 (3) | 0 |
3 hours ago | 5 / 5 (1) | 0
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
9 hours ago | 3.3 / 5 (10) | 0 |